163 related articles for article (PubMed ID: 22872024)
1. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.
Ciccia F; Alessandro R; Rizzo A; Raimondo S; Giardina A; Raiata F; Boiardi L; Cavazza A; Guggino G; De Leo G; Salvarani C; Triolo G
Ann Rheum Dis; 2013 Feb; 72(2):258-64. PubMed ID: 22872024
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC
Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227
[TBL] [Abstract][Full Text] [Related]
3. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Queralt C; Grau JM; Urbano-Márquez A; Palacín A; Colomer D; Cid MC
Rheumatology (Oxford); 2004 Mar; 43(3):294-301. PubMed ID: 14679293
[TBL] [Abstract][Full Text] [Related]
4. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.
Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH
Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090
[TBL] [Abstract][Full Text] [Related]
6. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
Baldini M; Maugeri N; Ramirez GA; Giacomassi C; Castiglioni A; Prieto-González S; Corbera-Bellalta M; Di Comite G; Papa I; Dell'antonio G; Ammirati E; Cuccovillo I; Vecchio V; Mantovani A; Rovere-Querini P; Sabbadini MG; Cid MC; Manfredi AA
Arthritis Rheum; 2012 Mar; 64(3):854-65. PubMed ID: 21989653
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.
Ciccia F; Alessandro R; Rizzo A; Principe S; Raiata F; Cavazza A; Guggino G; Accardo-Palumbo A; Boiardi L; Ferrante A; Principato A; Giardina A; De Leo G; Salvarani C; Triolo G
Arthritis Rheum; 2011 Jul; 63(7):2097-104. PubMed ID: 21452292
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis.
Bolha L; Hočevar A; Suljič A; Jurčić V
Front Immunol; 2021; 12():791099. PubMed ID: 35003111
[TBL] [Abstract][Full Text] [Related]
9. Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.
Ciccia F; Rizzo A; Guggino G; Cavazza A; Alessandro R; Maugeri R; Cannizzaro A; Boiardi L; Iacopino DG; Salvarani C; Triolo G
Rheumatology (Oxford); 2015 Sep; 54(9):1596-604. PubMed ID: 25862016
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptors in giant cell arteritis. An immunocytochemical, western blot and RT-PCR study.
Petursdottir V; Nordborg E; Moraghebi N; Persson M; Nordborg C
Clin Exp Rheumatol; 1999; 17(6):671-7. PubMed ID: 10609065
[TBL] [Abstract][Full Text] [Related]
11. Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2010 Mar; 117(3):628-36. PubMed ID: 20036012
[TBL] [Abstract][Full Text] [Related]
12. Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.
Espígol-Frigolé G; Planas-Rigol E; Lozano E; Corbera-Bellalta M; Terrades-García N; Prieto-González S; García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC
Front Immunol; 2018; 9():809. PubMed ID: 29731755
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
[TBL] [Abstract][Full Text] [Related]
14. Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
Graver JC; Jiemy WF; Altulea DHA; van Sleen Y; Xu S; van der Geest KSM; Verstappen GMPJ; Heeringa P; Abdulahad WH; Brouwer E; Boots AMH; Sandovici M
J Autoimmun; 2023 Nov; 140():103111. PubMed ID: 37703805
[TBL] [Abstract][Full Text] [Related]
15. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Malmsjö M; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2009 May; 116(5):990-6. PubMed ID: 19410957
[TBL] [Abstract][Full Text] [Related]
16. Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures.
Blain H; Abdelmouttaleb I; Belmin J; Blain A; Floquet J; Guéant JL; Jeandel C
J Gerontol A Biol Sci Med Sci; 2002 Apr; 57(4):M241-5. PubMed ID: 11909890
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of interleukin-22 in patients with giant cell arteritis.
Zerbini A; Muratore F; Boiardi L; Ciccia F; Bonacini M; Belloni L; Cavazza A; Cimino L; Moramarco A; Alessandro R; Rizzo A; Parmeggiani M; Salvarani C; Croci S
Rheumatology (Oxford); 2018 Jan; 57(1):64-72. PubMed ID: 28968695
[TBL] [Abstract][Full Text] [Related]
18. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.
Ly KH; Régent A; Molina E; Saada S; Sindou P; Le-Jeunne C; Brézin A; Witko-Sarsat V; Labrousse F; Robert PY; Bertin P; Bourges JL; Fauchais AL; Vidal E; Mouthon L; Jauberteau MO
Arthritis Res Ther; 2014 Nov; 16(6):487. PubMed ID: 25418464
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.
Lozano E; Segarra M; Corbera-Bellalta M; García-Martínez A; Espígol-Frigolé G; Plà-Campo A; Hernández-Rodríguez J; Cid MC
Ann Rheum Dis; 2010 Feb; 69(2):434-42. PubMed ID: 19289383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
